Important Changes in UK Law on Reproductive and Genetic Technologies
By David King,
Genetic Crossroads
| 01. 26. 2007
Editor's note:
Many consider the UK approach to human biotechnologies to be a model of comprehensive and responsible policy. Since its creation in 1990, a government agency called the Human Fertilisation and Embryology Authority (HFEA) has set and enforced regulations for assisted reproductive technology and research involving human embryos. Observers often contrast this situation to the "Wild West" in the United States, where regulation and public oversight of these technologies are minimal.
Here, Dr. David King gives his views on government proposals that would reorganize the HFEA and set important new rules. King is a former molecular biologist and director of Human Genetics Alert, an independent watchdog group based in London.
By David King, PhD
In December, the UK government published a set of proposals that would reform the Human Fertilization and Embryology Act. The legislation dates from 1990; in recent years scientific developments and changes in social attitudes have made it increasingly outdated.
The government's proposals follow a public consultation on the law in 2005, and precede publication later this year of draft legislation, which will be scrutinized...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...